Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy

NCT04711330 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer Stage III
Immunotherapy

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]